Advanced search
Publication Cover
Health Marketing Quarterly Volume 31, 2014 - Issue 3
Submit an article Journal homepage
857
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Awareness of and Attitudes Toward Direct-to-Consumer Prescription Drug Advertising Among Young Adults

Neil M. Alperstein Department of Communication, Loyola University Maryland, Baltimore, MarylandCorrespondence[email protected]
Pages 231-245 | Published online: 13 Aug 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Erika Katherine Johnson. (2023) Telemedicine and direct to consumer advertising attitudes and the future of telehealth: Women report telemedicine as a comfortable option for accessing birth control. Health Marketing Quarterly 40:3, pages 309-325.
Read now
Helen W. Sullivan & Miriam Campbell. (2015) Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration. Journal of Health Communication 20:12, pages 1391-1396.
Read now

Articles from other publishers (4)

Kristen Giombi, Jessica Thompson, Candi Wines, Ryan Haughney, Helen W. Sullivan & Kevin R. Betts. (2023) A scoping review of empirical research on prescription drug promotion. Research in Social and Administrative Pharmacy 19:6, pages 859-872.
Crossref
Jessica A. Dugan & Patricia J. Bauer. (2022) This should help with that: A behavioral investigation into self‐derivation of knowledge about prescription medications. Applied Cognitive Psychology 36:2, pages 378-390.
Crossref
Young-Mo Yang, Jae-Joon Lee, Eun Jeong, Sun Young Kim, Mi Ah Han & Eun Joo Choi. (2018) A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea. PLOS ONE 13:7, pages e0201108.
Crossref
Helen W. Sullivan, Kathryn J. Aikin, Eunice Chung-Davies & Michael Wade. (2016) Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration. PLOS ONE 11:5, pages e0155035.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.